Loading clinical trials...

Pazopanib for Metastatic Alveolar Soft Part Sarcoma | Clinical Trials | Clareo Health

TERMINATEDPhase 2NCT02113826

Pazopanib for Metastatic Alveolar Soft Part Sarcoma

Alveolar soft part sarcoma (ASPS), a rare subset of STS (\<1%) harbors t(X;17)(p11;q25) translocation and produces resultant ASPL-TFE3 fusion protein. Due to its nature of high expression of angiogeni...

Lead sponsor: Seoul National University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

NCT06066138 · Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, and more

COMPLETEDPhase 2

CREATE: Cross-tumoral Phase 2 With Crizotinib

NCT01524926 · Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma, Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 6, 2017Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment6

Start dateApr 2014

Last updatedNov 6, 2017

Condition

Metastatic Alveolar Soft Part Sarcoma

Locations shown

Seoul National University Hospital

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 6, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions